Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Amyotrophic Lateral Sclerosis
Related studies linked through entity extraction aliases.
Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients
- Status
- COMPLETED
- Phase
- PHASE2
The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
HEALEY ALS Platform Trial - Regimen D Pridopidine
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
- Status
- TERMINATED
- Phase
- PHASE2
Exploratory Evaluation of [11C]MPC6827
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
- Status
- COMPLETED
- Phase
- PHASE2
The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry
- Status
- COMPLETED
- Phase
- N/A
Open Label Study: Treatment of ALS Fatigue With PolyMVA
- Status
- COMPLETED
- Phase
- PHASE1
Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis
- Status
- UNKNOWN
- Phase
- NA
A Compassionate Use Protocol of AMX0035 for Treatment of Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
- Status
- COMPLETED
- Phase
- NA
Fatigue in Patients With Amyotrophic Lateral Sclerosis
- Status
- WITHDRAWN
- Phase
- NA
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
- Status
- RECRUITING
- Phase
- N/A